Latham & Watkins LLP has advised the selling shareholder group, including Syz Capital, Saturnus Capital, and the founder, on the sale of SK Pharma Logistics GmbH (SK Pharma), a pure-play provider of logistics solutions to the healthcare industry in Germany, to Arcus European Infrastructure Fund 4 (AEIF4), managed by Arcus Infrastructure Partners. AEIF4 has entered into a definitive agreement to acquire SK Pharma alongside the reinvesting management team. The transaction is expected to complete in Q4 2026, subject to relevant regulatory clearances.
The Latham team was led by Munich corporate partner Burc Hesse, with associates Chris Freitag, Sara Collorio, and Giulia Zöller. Advice was also provided on tax matters by Munich counsel Daniel Hiemer; on finance matters by Munich partner Christian Jahn, with associates Valentin Mezger and Thomas Stüber; on antitrust matters by Frankfurt partner Max Hauser, with associates David Marder and Kamilla Zembala; and on regulatory matters by Frankfurt partners Deniz Tschammler, Axel Schiemann, and Joachim Grittmann.
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.From Legal Desire
Is your firm the one being cited, or the one being skipped?
We ran the test. On several everyday legal questions, software companies are answering and law firms are not. We help firms fix that, and we build the technology behind the practice.
The advising firms, the named deal team, the value and the parties, with every other announced deal by the same firms and lawyers. Open the deal record
